EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy

Aowei Lv, Yaofeng Fang, Xiaohong Lin, Jiaying Chen, Huanhuan Song, Ning Wang iD, Wan-Jin Chen iD, Ying Fu iD, Rui Li iD, Yi Lin

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52190 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Aowei Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Ne…. Hauptthemen laut MEDLINE: B-Lymphocytes, Paraparesis, Tropical Spastic, Human T-lymphotropic virus 1, Rituximab. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds for the Innovation of Science and Technology of Fujian Province, Fujian Province Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Human T‐cell leukemia virus type 1‐associated myelopathy (HAM) is a chronic, progressive, inflammatory disease with unclear pathogenesis and no effective treatments. We aimed to investigate a novel mechanistic theory and treat HAM patients with rituximab, which can deplete CD20 + B lymphocytes in circulation.

Methods

Single‐cell RNA sequencing (scRNA‐seq) data was analyzed to identify HTLV‐1‐associated B cells and their effect on T cells. An observational analysis of our HAM cohort was conducted to elucidate changes in the immunological microenvironment of these patients. Peripheral blood mononuclear cells (PBMC) from HAM patients were isolated to explore the efficacy of B cell depletion in vitro. To assess the effect of B‐cell depletion on HAM patients, eligible participants in our cohort received rituximab therapy (NCT04004819).

Results

ScRNA‐seq results suggest a significant effect of HTLV‐1‐associated B cells on T cells. Additionally, HTLV‐1 was found to infect B cells and depletion of B cells inhibited the proliferation of T cells. Number of B cells in HAM patients had positive correlation with the proviral load and infected cell counts. Depletion of B cells led to a reduction in HTLV‐1 proviral load in vitro. Furthermore, in clinical trial, 14 HAM patients were enrolled. Three patients (21.4%) who received rituximab failed to achieve remission, compared to 24 (85.7%) patients received any other therapy that failed to achieve remission. With a low level of circulating B cells, the proportion of Ki67‐positive cells in CD4 + T cells fell.

Interpretation

This study provided evidence that depleting B‐lymphocytes is an innovative strategy for treating patients with HAM and broadens the understanding of the role of B cells in infectious immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesParaparesis, Tropical SpasticHuman T-lymphotropic virus 1RituximabT-LymphocytesHumansMaleFemaleMiddle AgedAgedAdultLymphocyte DepletionImmunologic Factors

Substanzen

RituximabImmunologic Factors

Autor:innen und Institutionen

  • Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, 350005, China.
  • Department of Rehabilitation, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
  • Institute of Immunotherapy and Department of Neurology of First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian, China.

ORCID-Profile: Ning Wang, Wan-Jin Chen, Ying Fu, Rui Li

Förderung

  • National Natural Science Foundation of China
  • Joint Funds for the Innovation of Science and Technology of Fujian Province
  • Fujian Province Science and Technology Plan Project

Zitieren

APA

Lv, A., Fang, Y., Lin, X., Chen, J., Song, H., Wang, N., Chen, W. J., Fu, Y., Li, R., & Lin, Y. (2024). B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52190

Vancouver

Lv A, Fang Y, Lin X, Chen J, Song H, Wang N, et al. B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52190

BibTeX
@article{Lv2024,
  author = {Lv, Aowei and Fang, Yaofeng and Lin, Xiaohong and Chen, Jiaying and Song, Huanhuan and Wang, Ning and Chen, Wan-Jin and Fu, Ying and Li, Rui and Lin, Yi},
  title = {B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52190}
}
Kostenlos starten →